U.S. Markets closed

Oxford Immunotec Global PLC (OXFD)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
13.98-0.21 (-1.48%)
At close: 4:00PM EDT

13.98 0.00 (0.00%)
After hours: 4:00PM EDT

People also watch
PHIIKPFISGBLINRCIANSTG
Interactive chart
Previous Close14.19
Open14.03
Bid10.15 x 100
Ask0.00 x
Day's Range13.84 - 14.12
52 Week Range7.73 - 16.13
Volume100,283
Avg. Volume113,049
Market Cap320.52M
Beta-0.15
PE Ratio (TTM)-13.40
EPS (TTM)-1.04
Earnings DateJul 31, 2017 - Aug 4, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est20.00
Trade prices are not sourced from all markets
  • Capital Cube6 hours ago

    ETFs with exposure to Oxford Immunotec Global Plc : May 26, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Oxford Immunotec Global Plc Here are 5 ETFs with the largest exposure to OXFD-US. Comparing the performance and risk of Oxford Immunotec Global Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Capital Cube21 days ago

    ETFs with exposure to Oxford Immunotec Global Plc : May 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Oxford Immunotec Global Plc Here are 5 ETFs with the largest exposure to OXFD-US. Comparing the performance and risk of Oxford Immunotec Global Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Oxford Immunotec Global Plc :OXFD-US: Earnings Analysis: Q1, 2017 By the Numbers : May 4, 2017
    Capital Cube22 days ago

    Oxford Immunotec Global Plc :OXFD-US: Earnings Analysis: Q1, 2017 By the Numbers : May 4, 2017

    Categories: Yahoo FinanceGet free summary analysis Oxford Immunotec Global Plc reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Oxford Immunotec Global Plc – Quidel Corporation, Psychemedics Corporation and Meridian Bioscience, Inc. (QDEL-US, PMD-US and VIVO-US) that have also reported for this period. Highlights Summary numbers: ... Read more (Read more...)